By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Despite the $1.7B Nebius deal, Bloom Energy's high valuation (95.6x forward P/E) and execution risks, including supply chain vulnerabilities and capital intensity, lead to a bearish consensus among panelists.
Risk: Capital intensity and potential equity dilution to fund massive deployments
Opportunity: Revenue visibility from the Nebius deal
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Solid oxide fuel cell systems provider Bloom Energy Corporation (BE) recently landed a $1.70 billion deal for fuel cell technology to power artificial intelligence (AI) cloud infrastructure. IDF and Oaktree Capital are committing the sum to Bloom to the meter power solutions for the AI operations of Nebius Group N.V. (NBIS). For investors optimistic about clean energy powering AI data centers, this deal, linking fuel cell energy with AI infrastructure, seems like a huge positive development.
However, investors did not react positively to the news. The stock dropped 13.64% intraday on July 16, as the market reacted to some other news surrounding Bloom Energy. The company's stock has come under pressure after a short report questioned its sourcing of Chinese scandium. The Hunterbrook report alleges that Bloom secretly relies on China for scandium, thereby putting its supply chain at risk. Investors have also noted some insider selling activity in the company's stock.
While Bloom might be on the beneficiary side of an AI infrastructure boom, there are some concerns surrounding it at the moment. We take a closer look at it now.
About Bloom Energy Stock
Bloom Energy develops and supplies solid oxide fuel cell solutions that generate on-site electricity and support nascent hydrogen use cases for customers. Its systems deliver distributed, lower-carbon power to AI data centers, semiconductor manufacturers, utilities, and a broad range of commercial and industrial facilities that need reliable, modular energy infrastructure.
The company's activities include designing, producing, installing, and servicing its fuel cell platforms, with core operations in the United States and an expanding presence abroad. Bloom Energy maintains its corporate headquarters in San Jose, California and has a market capitalization of $58.80 billion.
Bloom Energy's huge move reflects its emergence as a high‑beta "AI power" proxy, as investors price in soaring demand for on-site fuel‑cell power from AI and cloud data centers.
Over the past 52 weeks, Bloom's stock has gained a whopping 784.3%, while it is up 147.4% year-to-date (YTD). The company's shares reached a 52-week high of $351.28 on June 25 but are down 38.6% from that level, having declined 24.6% over the past month.
On a forward-adjusted basis, Bloom's price-to-earnings (non-GAAP) ratio of 95.59 times is stretched compared to the industry average of 21.42 times.
Bloom Energy Posted Record Q1 2026 Revenue, Raises Full-Year Outlook
For the first quarter, Bloom Energy reported record results driven by solid demand for its on-site power solutions. The company's revenues increased by 130.4% year-over-year (YOY) to $751.05 million. Its non-GAAP operating margin moved from just 4% to 17.3% over the same period. Its non-GAAP EPS for the quarter was $0.44, up significantly YOY. Based on these results, Bloom raised its full-year revenue growth outlook from approximately 60% to 80% YOY.
Street analysts are robustly optimistic about Bloom's bottom-line trajectory. For the current fiscal year, EPS is projected to surge considerably annually to $1.43, followed by a 160.1% increase to $3.72 in the next fiscal year. The company is expected to report its second-quarter 2026 results on July 28, after the market closes. Ahead of that, analysts expect its EPS to grow significantly by 866.7% to $0.23 for Q2.
What Analysts Think About Bloom Energy's Stock
This month, Clear Street analyst Tim Moore reaffirmed a "Hold" rating on Bloom Energy's stock and assigned a $290 price target. Moore noted that the company's shares have come under pressure as AI chip stocks have experienced a sell-off since mid-June. Also, the analyst highlighted the recent scandium report.
Additionally, Truist analyst Christopher Souther initiated with a "Hold" rating and a $250 price target, pointing toward the company's AI-driven surge but also recommending waiting for the stock's value to normalize.
Susquehanna analysts kept a "Positive" rating on Bloom Energy's stock and raised the price target from $293 to $298. Susquehanna updated its estimates and target ahead of Q2 results, taking into account the company's power demand growth, driven by data centers and electrification.
Baird analysts reiterated an "Outperform" rating on Bloom Energy's stock and a $310 price target despite the scandium short report. Analysts noted that the report recycled multiple bear arguments.
Wall Street analysts are still taking a positive stance on Bloom's stock now, with a consensus "Moderate Buy" rating overall. Of the 27 analysts rating the stock, eight analysts gave a "Strong Buy" rating, two analysts gave a "Moderate Buy" rating, 16 analysts are playing it safe with a "Hold" rating, and one analyst gave a "Strong Sell" rating. The consensus price target of $271.04 represents a 25.7% upside from current levels. Moreover, the Street-high price target of $390 indicates an 80.9% upside from current levels.
On the date of publication, Anushka Dutta did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Four leading AI models discuss this article
"The Nebius contract is strategically important but insufficient to close the gap between Bloom’s explosive growth narrative and its stretched 95.6x forward P/E."
The $1.7B Nebius deal is real validation that solid-oxide fuel cells are becoming a credible on-site power solution for AI data centers, especially where grid constraints bite. Bloom’s Q1 beat (130% rev growth, 17.3% non-GAAP op margin) and raised 80% FY guide look impressive, yet the 95.6x forward P/E versus 21.4x industry average already prices in heroic execution. The 784% 52-week run and 38% pullback from highs reflect classic high-beta AI-proxy volatility. Scandium sourcing risk and insider selling are real but probably secondary; the bigger issue is whether Bloom can scale production and gross margins fast enough to justify the multiple before 2027.
At 95x forward earnings the stock needs to compound EPS at 50%+ annually for years just to grow into its valuation; any delay in the $1.7B deployment, margin slippage, or renewed short attacks on China supply could trigger a 40-50% de-rating.
"Bloom Energy’s current valuation assumes flawless execution in an increasingly complex geopolitical supply chain, leaving zero margin for error in its upcoming earnings print."
Bloom Energy’s $1.7 billion financing deal is a massive vote of confidence in its 'behind-the-meter' power architecture, but the market's 13% sell-off reflects a justified repricing of risk. Trading at a 95x forward P/E, Bloom is priced for perfection, not for supply chain volatility or regulatory friction. While the AI data center narrative is compelling, the Hunterbrook report on Chinese scandium sourcing highlights a critical geopolitical vulnerability that could derail margin expansion if export controls tighten. With Q2 results approaching, investors are pivoting from 'growth at any cost' to scrutinizing the sustainability of these margins. I expect significant volatility as the market reconciles the $3.72 EPS projection with the reality of high execution risk.
The market may be overreacting to the scandium report, as Bloom’s proprietary fuel cell technology is modular and potentially adaptable to alternative materials, making the supply chain risk a manageable hurdle rather than a structural failure.
"The $1.7B deal validates AI power demand but doesn't justify a 95.6x forward P/E when supply-chain risk and margin sustainability remain unproven."
The $1.7B Nebius deal is real revenue visibility, but the 95.6x forward P/E already prices in heroic execution. Q1's 130% revenue growth and 17.3% operating margin are impressive, yet the stock fell 13.6% on the news—a red flag that the market is repricing risk faster than the article acknowledges. The Hunterbrook scandium report may be recycled bear noise, but supply chain concentration in China for a critical material during U.S.-China tech tensions is a material operational risk, not just short-seller FUD. The real question: can BE sustain 80% YoY growth while expanding margins AND resolving supply-chain vulnerability? The consensus $271 target implies only 25.7% upside from here—modest for a stock that's been a 784% gainer in 12 months.
If BE's margins compress as it scales (common in manufacturing), or if the Nebius deal is one-off rather than proof of repeatable enterprise demand, the 160% EPS growth forecast for next year collapses and the stock re-rates to 30-40x forward P/E, not 95x.
"BE's sky-high valuation and potential reliance on a single large project (with unresolved supply-chain risk) imply meaningful downside unless Nebius proves durable and margins expand."
Bloom Energy lands a $1.7B AI data-center deal, a bullish signal for AI-powered clean energy. Q1 2026 revenue rose 130% YoY and margins expanded, supporting a higher outlook. Yet the headline momentum masks red flags: the valuation is steep (non-GAAP forward P/E near 96x vs ~21x industry), and contract details plus lifecycle margins are unclear. The Nebius tie-up could be a large, one-off project rather than a scalable growth engine. Scandium sourcing concerns and insider selling add overhang, and the stock remains highly sensitive to AI capex cycles and policy incentives that could fade if AI demand cools.
The Nebius contract may be a one-off, low-margin project that won't guarantee durable revenue; and the scandium-sourcing risk could escalate, undermining the valuation.
"Nebius visibility is front-loaded; absent a demonstrated order book, 95x P/E cannot be justified past 2026."
Claude correctly flags the modest $271 consensus target after a 784% run, but everyone underweights second-order execution risk on the Nebius rollout timeline. A single large 2026-2027 deployment can't sustain 80% YoY growth into 2028 without a visible pipeline of follow-on orders; without that, the 160% EPS growth forecast collapses well before 2027, forcing an earlier de-rating regardless of scandium.
"The primary risk is balance sheet strain and potential dilution required to fund capital-intensive data center deployments, not just valuation multiples."
Grok and Claude are fixated on the P/E, but you’re all missing the utility-scale capital intensity. Bloom’s model requires massive upfront deployment costs. If Nebius isn't just a one-off, the real risk isn't just supply chain or multiples—it’s the balance sheet. Can Bloom finance these massive deployments without dilutive equity raises? At 95x forward earnings, any secondary offering to fund growth would be catastrophic for existing shareholders. The market isn't just pricing execution; it's pricing liquidity risk.
"Bloom's liquidity runway, not its P/E multiple or supply chain, is the binding constraint on whether the Nebius deal scales or forces dilutive financing."
Gemini's balance-sheet risk is the hardest problem in the room and everyone glossed it. Bloom burned $89M operating cash in 2025 despite revenue growth. If Nebius deployment requires $500M+ capex upfront while revenue recognition lags, equity dilution becomes inevitable—and at 95x forward P/E, that's a 30-40% haircut before margins even compress. The P/E debate is noise if the company runs out of cash.
"Large front-loaded capex and financing constraints could slow Nebius deployment, causing dilution and margin compression that derail Bloom's 80% growth path."
Grok, I agree Nebius creates revenue visibility, but the defense relies on a fragile tempo: even with a scalable deployment path, Bloom’s growth hinges on capital cadence, not just orders. Large front-loaded capex and working capital need debt capacity and potentially equity raises; any delay or tighter covenants could slow rollouts, trigger dilution, and compress margins, which would undermine the 80% YoY trajectory and threaten the 95x multiple.
Despite the $1.7B Nebius deal, Bloom Energy's high valuation (95.6x forward P/E) and execution risks, including supply chain vulnerabilities and capital intensity, lead to a bearish consensus among panelists.
Revenue visibility from the Nebius deal
Capital intensity and potential equity dilution to fund massive deployments